Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

62 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Onset and dose-related efficacy of house dust mite sublingual immunotherapy tablets in an environmental exposure chamber.
Nolte H, Maloney J, Nelson HS, Bernstein DI, Lu S, Li Z, Kaur A, Zieglmayer P, Zieglmayer R, Lemell P, Horak F. Nolte H, et al. Among authors: zieglmayer r, zieglmayer p. J Allergy Clin Immunol. 2015 Jun;135(6):1494-501.e6. doi: 10.1016/j.jaci.2014.12.1911. Epub 2015 Jan 27. J Allergy Clin Immunol. 2015. PMID: 25636947 Clinical Trial.
Molecular, Structural and Immunological Characterization of Der p 18, a Chitinase-Like House Dust Mite Allergen.
Resch Y, Blatt K, Malkus U, Fercher C, Swoboda I, Focke-Tejkl M, Chen KW, Seiberler S, Mittermann I, Lupinek C, Rodriguez-Dominguez A, Zieglmayer P, Zieglmayer R, Keller W, Krzyzanek V, Valent P, Valenta R, Vrtala S. Resch Y, et al. Among authors: zieglmayer r, zieglmayer p. PLoS One. 2016 Aug 22;11(8):e0160641. doi: 10.1371/journal.pone.0160641. eCollection 2016. PLoS One. 2016. PMID: 27548813 Free PMC article.
Clinical validation of a house dust mite environmental challenge chamber model.
Zieglmayer P, Lemell P, Chen KW, Schmutz R, Zieglmayer R, Pfaar O, Horak F, Vrtala S. Zieglmayer P, et al. Among authors: zieglmayer r. J Allergy Clin Immunol. 2017 Jul;140(1):266-268.e5. doi: 10.1016/j.jaci.2016.12.986. Epub 2017 Feb 24. J Allergy Clin Immunol. 2017. PMID: 28238743 No abstract available.
Underestimation of house dust mite-specific IgE with extract-based ImmunoCAPs compared with molecular ImmunoCAPs.
Huang HJ, Resch-Marat Y, Rodriguez-Dominguez A, Chen KW, Kiss R, Zieglmayer P, Zieglmayer R, Lemell P, Horak F, Valenta R, Vrtala S. Huang HJ, et al. Among authors: zieglmayer r, zieglmayer p. J Allergy Clin Immunol. 2018 Nov;142(5):1656-1659.e9. doi: 10.1016/j.jaci.2018.07.010. Epub 2018 Jul 27. J Allergy Clin Immunol. 2018. PMID: 30059698 Free article. No abstract available.
Selection of house dust mite-allergic patients by molecular diagnosis may enhance success of specific immunotherapy.
Chen KW, Zieglmayer P, Zieglmayer R, Lemell P, Horak F, Bunu CP, Valenta R, Vrtala S. Chen KW, et al. Among authors: zieglmayer r, zieglmayer p. J Allergy Clin Immunol. 2019 Mar;143(3):1248-1252.e12. doi: 10.1016/j.jaci.2018.10.048. Epub 2018 Nov 14. J Allergy Clin Immunol. 2019. PMID: 30445063 Free article. Clinical Trial. No abstract available.
Perspectives in allergen immunotherapy: 2019 and beyond.
Pfaar O, Agache I, de Blay F, Bonini S, Chaker AM, Durham SR, Gawlik R, Hellings PW, Jutel M, Kleine-Tebbe J, Klimek L, Kopp MV, Nandy A, Rabin RL, van Ree R, Renz H, Roberts G, Salapatek AM, Schmidt-Weber CB, Shamji MH, Sturm GJ, Virchow JC, Wahn U, Willers C, Zieglmayer P, Akdis CA. Pfaar O, et al. Among authors: zieglmayer p. Allergy. 2019 Dec;74 Suppl 108:3-25. doi: 10.1111/all.14077. Allergy. 2019. PMID: 31872476 Review.
62 results